COVID-19 vaccine scam alert
The City of Chicago and CDPH are warning residents about COVID-19 vaccine scams. If you or someone you know gets calls, texts, or emails offering early access to a COVID-19 vaccine, it is NOT legitimate, it is a scam, and you should not respond. Read the full CDPH statement here.
January 19, 2021
Beginning Monday, January 25th, Chicago will formally move into Vaccination Phase 1b—meaning we will start to ramp up vaccination for Chicago residents >65 and specific groups of highest-risk or front-line essential workers. Learn more about Chicago's vaccination phases.
January 19, 2021
Chi COVID Coach for vaccine updates
Sign up for Chi COVID Coach to stay informed on the COVID-19 vaccine. Messages and other updates on vaccine distribution, phases and when you can register for the vaccine will be sent. Registration is free and your information will be protected and only used by the Chicago Department of Public Health (CDPH) for public health purposes related to COVID-19.
January 14, 2021
Chicago opens two new mass vaccination sites
Mayor Lightfoot and the Chicago Department of Public Health (CDPH) announced the opening of two new mass vaccination sites to increase distribution of the COVID-19 vaccine to non-hospital and other community-based healthcare workers.
January 13, 2021
The City of Chicago is making plans for a transitional COVID-19 vaccine distribution phase, bridging phase 1A and 1B. Hospitals and outpatient sites enrolled as COVID-19 vaccine providers will continue to prioritize healthcare workers, especially non-hospital based healthcare workers in tier 1A, for vaccination. Starting January 18, if vaccination providers have vaccine available and do not have tier 1A healthcare workers scheduled for vaccination, they may move to highest risk individuals that are over 65 years old and live or work in Chicago.
Prioritization will be given to patients over 75 years of age, or patients over 65 years of age with significant underlying conditions, based on clinical judgment. City-run Points of Dispensing (PODs) will continue to focus on providing vaccine to tier 1A healthcare workers, by appointment only.
January 11, 2021
Tier 1A Non-hospital based healthcare workers
Non-hospital based facilities should complete the Staff Vaccination Inquiry Survey to coordinate COVID-19 vaccines for their staff. Pre-registration and an appointment, coordinated by the facility is required. Walk-up appointments are not available.
January 8, 2021
Long-term care vaccinations
Robin Meier a resident at Alden Estates of Northmoor gives a thumbs up after receiving her first dose of the COVID-19 vaccine. CDPH is partnering with Walgreens, CVS, and PharmScript to vaccinate staff and residents in long-term care facilities.
January 5, 2021
Second doses begin at hospitals
Dr. Marina Del Rios, Director of Social Emergency Medicine, University of Illinois Health received her second dose of the COVID-19 vaccine at Norwegian American Hospital.
December 29, 2020
Commissioner receives first dose
Dr. Allison Arwady, Commissioner, CDPH received her first dose of the COVID-19 vaccine at Malcolm X College. As a practicing healthcare worker who sees patients at the Community Health Chicago Clinic, she hopes that being vaccinated publicly will demonstrate her confidence in its safety and effectiveness.
December 17, 2020
Virtual Vaccine Town Hall
- When FDA first authorizes or approves the use of one or more COVID-19 vaccines, there will be a limited supply. This would mean that not everyone will be able to be vaccinated right away.
- While the supply is limited, certain groups (e.g. healthcare workers) will be prioritized to receive vaccine, based on national guidance.
- CDPH has been working with health care and community partners to increase our ability to quickly distribute a large amount of COVID-19 vaccine, as it becomes available.
- Supplies will increase over time, and it is anticipated all adults should be able to get vaccinated later in 2021. As the vaccine supplies increases, COVID-19 vaccine will be available through additional vaccination providers, including doctors’ offices, retail pharmacies, hospitals, and federally qualified health centers. A map of convenient vaccination locations will be posted on this website.
This work group will independently evaluate whether or not the proper scientific and regulatory review has taken place prior to approval by the FDA for use of Pfizer's and Moderna's vaccines under Emergency Use Authorization (EUA). Work group members have nationally recognized expertise in areas including vaccines, infectious diseases, clinical trials, statistics, regulatory affairs, and public health.
The work group met on December 21 and, after reviewing numerous materials posted on the FDA website, concluded that the FDA’s evaluation of Moderna's clinical trial data was rigorous, and the decision-making process for issuing the EUA for the Moderna vaccine was transparent and sound. The FDA’s decision to issue an EUA for the Moderna COVID-19 vaccine was grounded in science, with careful consideration of currently known benefits and risks, in the setting of a public health emergency. Accelerated vaccine development and approval did not sacrifice scientific standards or the integrity of the FDA evaluation process. Read the full Work Group Report: December 21, 2020.
The work group met on December 13 and, after reviewing numerous materials posted on the FDA website, concluded that the FDA’s evaluation of Pfizer’s clinical trial data was rigorous, and the decision-making process for issuing the EUA for the Pfizer-BioNTech vaccine was transparent and sound. The FDA’s decision to issue an EUA for the Pfizer-BioNTech COVID-19 vaccine was grounded in science, with careful consideration of currently known benefits and risks, in the setting of a public health emergency. Accelerated vaccine development and approval did not sacrifice scientific standards or the integrity of the FDA evaluation process. Read the full Work Group Report: December 13, 2020.
Anup Malani, PhD, JD
Lee and Brena Freeman Professor, University of Chicago Law School
Eve Shapiro, MPH
Director of Data and Evaluation, West Side United
Elizabeth Aquino, PhD, RN
Associate Professor, DePaul University School of Nursing
Daniel Johnson, MD
Professor of Pediatrics, University of Chicago Medicine/Comer Children’s Hospital Department of Pediatrics
Kelly Michelson, MD, MPH
Attending Physician, Ann & Robert H. Lurie Children's Hospital of Chicago
Professor of Pediatrics and Julia and David Uihlein Professor of Bioethics and Medical Humanities, Northwestern University Feinberg School of Medicine
Robert A. Weinstein, M.D.
The C. Anderson Hedberg MD, Professor of Internal Medicine, Rush University Medical Center
Chairman Emeritus, Department of Medicine, Cook County Hospital
Yuan Ji, PhD
Professor of Biostatistics, Department of Public Health Sciences, The University of Chicago
Charlesnika T. Evans
Professor of Preventive Medicine, Northwestern University
Ann Muñana, MSN, MJ, RN
Senior Manager, State Licensing and Regulation, Chamberlain University
President Emeritus, Rush University
Retired CEO, Rush University Medical Center and the Rush University System for Health
Latania K. Logan, MD, MSPH
Associate Professor of Pediatric Infectious Diseases, Rush University Medical Center, Rush Medical College
Stephanie Y. Crawford, PhD, MPH
Professor, Department of Pharmacy Systems, Outcomes and Policy
Executive Associate Dean for Faculty Affairs and Strategic Initiatives, University of Illinois at Chicago College of Pharmacy
Wayne H. Giles, MD, MS
Dean, UIC School of Public Health
Phoenix A. Matthews, Ph.D.
Professor and Associate Dean for Equity and Inclusion, University of Illinois at Chicago, College of Nursing
Horace E Smith, MD
Assistant Professor of Pediatrics (Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine
Sonali M. Smith, MD
Elwood V. Jensen Professor in Medicine, Chief, Section of Hematology/Oncology, Director, Lymphoma Program, University of Chicago Medicine
William Wong, MD, MPH, FACP
Occupational Medicine Physician, Corporate Health, Northwestern Medicine
Health System Clinician, Northwestern University Feinberg School of Medicine
Based on national level guidance, healthcare workers will be the first population recommended to receive the vaccine, and even then, those who treat COVID-19 patients and perform certain procedures will likely receive the vaccine first.
Healthcare personnel continue to be on the front line of the nation’s fight against this deadly pandemic. By providing critical care to those infected with the virus that causes COVID-19, many healthcare personnel have a high risk of being exposed to and getting sick with COVID-19. Healthcare personnel who get COVID-19 can also spread the virus to their patients seeking care for medical conditions that, in turn, increase their patients’ risk for severe COVID-19 illness. Early vaccine access is critical to ensuring the health and safety of this essential workforce of approximately 21 million people, protecting not only them but also their patients, communities, and the broader health of our country.